{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:25:45Z","timestamp":1791278745429,"version":"4.1.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,24]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Direct-acting antiviral agents are able to induce lymphoma response in patients with HCV-associated indolent non-Hodgkin lymphoma. The highest rate of lymphoma response (73%) was observed in patients with marginal zone lymphoma.<\/jats:p>","DOI":"10.1182\/blood-2016-05-714667","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T21:59:20Z","timestamp":1473285560000},"page":"2527-2532","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":155,"title":["Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection"],"prefix":"10.1182","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9504-991X","authenticated-orcid":false,"given":"Luca","family":"Arcaini","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy;"},{"name":"Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-7173","authenticated-orcid":false,"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Centre Hospitalier Universitaire Bic\u00eatre, Universit\u00e9 Paris Sud, INSERM, Le Kremlin-Bic\u00eatre, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-7749","authenticated-orcid":false,"given":"Marco","family":"Frigeni","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-369X","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Fontaine","sequence":"additional","affiliation":[{"name":"Paris 5 Descartes University, INSERM U1213 and Unit\u00e9 mixte de service 20, Institut Pasteur, Department of Hepatology, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Goldaniga","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-6808","authenticated-orcid":false,"given":"Milvia","family":"Casato","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Sapienza University of Rome, Fondazione Roma, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-6091","authenticated-orcid":false,"given":"Marcella","family":"Visentini","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology, Sapienza University of Rome, Fondazione Roma, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0814-604X","authenticated-orcid":false,"given":"Harrys A.","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6951-0784","authenticated-orcid":false,"given":"Veronique","family":"Loustaud-Ratti","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Centre Hospitalier Universitaire Limoges, U850 INSERM, University of Limoges, Limoges, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Peveling-Oberhag","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Goethe University Hospital, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fabris","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Ospedale San Bortolo, Vicenza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4965-8789","authenticated-orcid":false,"given":"Roberto","family":"Rossotti","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Ospedale Niguarda Ca\u2019 Granda, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3995-8817","authenticated-orcid":false,"given":"Francesco","family":"Zaja","sequence":"additional","affiliation":[{"name":"Hematology Unit, Centro Trapianti e Terapie Cellulari Carlo Melzi, Dipartimento di Scienze Mediche Sperimentali e Cliniche, Azienda Sanitaria Universitaria Integrata, Udine, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Rigacci","sequence":"additional","affiliation":[{"name":"Department of Hematology Azienda Ospedaliero-Universitaria Careggi, Florence, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2682-3414","authenticated-orcid":false,"given":"Sara","family":"Rattotti","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-9207","authenticated-orcid":false,"given":"Raffaele","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Clinical Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy;"},{"name":"Division of Infectious and Tropical Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-5927","authenticated-orcid":false,"given":"Michele","family":"Merli","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Dorival","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, Pierre and Marie Curie University (University of Paris 06), INSERM, Institut Pierre Louis d\u2019\u00e9pid\u00e9miologie et de Sant\u00e9 Publique (Unit\u00e9 mixte de recherche S1136), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0676-7539","authenticated-orcid":false,"given":"Laurent","family":"Alric","sequence":"additional","affiliation":[{"name":"Toulouse 3 University, Unit\u00e9 mixte de recherche 152 Institut de Recherche pour le D\u00e9veloppement, Department of Internal Medicine and Digestive Diseases, H\u00f4pital Purpan, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Jaccard","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Centre Hospitalier Universitaire Limoges, U850 INSERM, University of Limoges, Limoges, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-9591","authenticated-orcid":false,"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[{"name":"Paris 5 Descartes University, INSERM U1213 and Unit\u00e9 mixte de service 20, Institut Pasteur, Department of Hepatology, H\u00f4pital Cochin, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8672-7918","authenticated-orcid":false,"given":"Fabrice","family":"Carrat","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, Pierre and Marie Curie University (University of Paris 06), INSERM, Institut Pierre Louis d\u2019\u00e9pid\u00e9miologie et de Sant\u00e9 Publique (Unit\u00e9 mixte de recherche S1136), Paris, France;"},{"name":"Public Health Department, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-915X","authenticated-orcid":false,"given":"Virginia Valeria","family":"Ferretti","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-0883","authenticated-orcid":false,"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"Department of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"Paris 5 Descartes University, Assistance Publique\u2013H\u00f4pitaux de Paris, Department of Adult Hematology and Imagine Institute, H\u00f4pital Necker, Paris, France; and"},{"name":"INSERM U1163, Centre National de la Recherche Scientifique \u00c9quipes de recherche labellis\u00e9es 8254, Universit\u00e9 Sorbonne Paris Cit\u00e9, Imagine Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2019111903493297400_B1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","article-title":"Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation","volume":"46","author":"Saadoun","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"2019111903493297400_B2","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2019111903493297400_B3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2019111903493297400_B4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111903493297400_B5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"2019111903493297400_B6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.23889","article-title":"Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study","volume":"90","author":"Michot","year":"2015","journal-title":"Am J Hematol"},{"key":"2019111903493297400_B7"},{"issue":"1","key":"2019111903493297400_B8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL Recommendations on Treatment of Hepatitis C 2015","volume":"63","author":"European Association for Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"2019111903493297400_B9","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"issue":"10","key":"2019111903493297400_B10","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/liv.12897","article-title":"HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents","volume":"35","author":"Carrier","year":"2015","journal-title":"Liver Int"},{"issue":"1","key":"2019111903493297400_B11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2014.09.031","article-title":"Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3\/NS4A inhibitor-based treatment. A case report","volume":"62","author":"Rossotti","year":"2015","journal-title":"J Hepatol"},{"issue":"15","key":"2019111903493297400_B12","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2014-12-618652","article-title":"Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment","volume":"125","author":"Sultanik","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2019111903493297400_B13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology"},{"issue":"27","key":"2019111903493297400_B14","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111903493297400_B15","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"suppl 1","key":"2019111903493297400_B16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13027","article-title":"Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives","volume":"36","author":"Asselah","year":"2016","journal-title":"Liver Int"},{"issue":"8","key":"2019111903493297400_B17","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"issue":"32","key":"2019111903493297400_B18","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.3748\/wjg.v20.i32.11054","article-title":"Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment","volume":"20","author":"Visco","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2019111903493297400_B19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111903493297400_B20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin\u2019s lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111903493297400_B21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jvh.12518","article-title":"The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis","volume":"23","author":"Peveling-Oberhag","year":"2016","journal-title":"J Viral Hepat"},{"issue":"2","key":"2019111903493297400_B22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V90.2.776","article-title":"Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection","volume":"90","author":"De Vita","year":"1997","journal-title":"Blood"},{"issue":"4","key":"2019111903493297400_B23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-129-4-199808150-00005","article-title":"Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection","volume":"129","author":"Andreone","year":"1998","journal-title":"Ann Intern Med"},{"issue":"9","key":"2019111903493297400_B24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia Vasculitis","volume":"128","author":"Cacoub","year":"2015","journal-title":"Am J Med"},{"issue":"48","key":"2019111903493297400_B25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jncimonographs\/lgu001","article-title":"Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia\/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Slager","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"4","key":"2019111903493297400_B26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","article-title":"ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma","volume":"24","author":"Dreyling","year":"2013","journal-title":"Ann Oncol"},{"issue":"2","key":"2019111903493297400_B27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clml.2014.07.002","article-title":"Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma)","volume":"15","author":"Tarella","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2019111903493297400_B28"},{"issue":"6","key":"2019111903493297400_B29","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/liv.12825","article-title":"Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization","volume":"35","author":"Torres","year":"2015","journal-title":"Liver Int"},{"issue":"3","key":"2019111903493297400_B30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111903493297400_B31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/21\/2527\/1397013\/blood714667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/21\/2527\/1397013\/blood714667.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:49:58Z","timestamp":1574135398000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/21\/2527\/35718\/Interferonfree-antiviral-treatment-in-Bcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":31,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,11,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-05-714667","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]}}}